FDA Cleared New SI-BONE Spinal Fusion System

The regulatory agency approved the iFuse Granite Onyx System for patients who suffer from low bone density.

Updated on Sept. 28, 2026 in Arthritis

Isometric editorial illustration of a matte titanium surgical bone-screw implant, highlighting its intricate thread design and porous texture. — The U.S. Food and Drug Administration granted 510(k) clearance to the iFuse Granite Onyx System, a device designed for spinal stabilization in patients with low bone density. AI Illustration. Upload story photo >

Live Poll

Do you believe new medical technology typically leads to better health outcomes for patients?

The U.S. Food and Drug Administration has granted 510(k) clearance to the iFuse Granite Onyx System. The device is specifically engineered to improve fixation for patients with low bone density undergoing spinal fusion.

Why it matters

The system addresses the high rate of mechanical failure at the top and bottom of fusion constructs in patients with poor bone quality. Historically, these patients have faced limited options for secure spinal stabilization.

The system utilizes a 3D-printed bone integration platform to reduce micromotion and enhance early fixation. It is supported by a clinical foundation that includes 190 peer-reviewed publications and 4 randomized controlled trials.

The players

U.S. Food and Drug Administration

The federal agency is responsible for protecting public health by ensuring the safety and efficacy of medical devices and drugs in the United States.

SI-BONE

Headquartered in Santa Clara, California, this medical device company specializes in surgical solutions for spinal and joint pathologies.

The details

The iFuse Granite Onyx System features an anatomy-specific thread form and a bone-density-specific surface designed for rapid osseointegration. By targeting loosening at the upper and lower instrumented vertebrae, the device aims to improve clinical outcomes for those with weakened skeletal structures.

SI-BONE began supporting physician procedures in 2009.
The FDA granted 510(k) clearance for the iFuse Granite Onyx on September 28, 2026.

Life Sciences
Sept. 29
FDA Granted Breakthrough Status to ScolimiR-3D Blood Test
Healthcare
Sept. 22
TriSalus Life Sciences Received FDA Clearance
Stroke
Sept. 28
FDA Cleared New Route 92 Medical Stroke Catheter

The Big Picture

The device clearance follows a pattern set by the clinical database of 190 peer-reviewed publications maintained by SI-BONE. This strategic focus on long-term data collection anchors the company's product trajectory within the broader evolution of evidence-based spinal surgery.

Patients with low bone density may now have access to a device specifically designed to reduce post-surgical mechanical failure in the spine. This could lead to more durable outcomes and potentially lower the necessity for revision surgeries for those with poor bone quality.

The takeaway

Advancements in surface technology and bone integration are increasingly allowing surgeons to operate on patients who were previously deemed high-risk for hardware failure. Patients should consult with their orthopedic specialists to determine if these new fixation options are suitable for their specific bone density profiles.